TipRanks on MSN

AlphaTON, Cyncado recaps preclinical mesothelioma data

AlphaTON Capital (ATON) and its wholly owned oncology-focused subsidiary Tarus Therapeutics, LLC, operating as Cyncado Therapeutics, issued a ...

BiTE-based immunotherapy strategy could point the way to a breakthrough for ovarian cancer patients

Results of a study led by researchers at Roswell Park Comprehensive Cancer Center show that combining two types of ...